Stem-Cell Heart Repair Questioned

A new analysis finds hundreds of discrepancies in publications from a German researcher who claims to have repaired diseased hearts using stem-cell therapy.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, HEIKENWAELDER HUGODozens of papers by a German cardiologist who claims to have succeeded in using bone marrow-derived stem cells to repair patients’ damaged hearts are riddled with errors and inconsistencies, according to an analysis published last week (July 2) in the International Journal of Cardiology.

Bodo-Eckehard Strauer, who retired from the University of Dusseldorf in 2009, first announced that the approach was successful in 2001. But many stem-cell scientists have been skeptical of the claims, reported Nature, and the University of Dusseldorf began investigating some of Strauer’s papers last December.

Now, researchers from Imperial College London in the U.K. have analyzed 48 of Strauer’s papers—which describe results from five clinical studies—and revealed various problems. For instance, the researchers found duplicate and overlapping reports of the same trials, each detailing contradictory experimental design, recruitment, and results. They also said that it was not clear whether the studies were randomized or not. In addition, the UK team spotted arithmetical miscalculations and statistical errors. In total, they found more than 200 discrepancies—defined as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems